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Clinical evidence suggest astrocytic abnormality in major depression (MD) while treatment
with anti-psychotic drugs affects astroglial functions. Astroglial cells are involved in pH
homeostasis of the brain by transporting protons (through sodium-proton transporter
1, NHE1, glutamate transporters EAAT1/2 and proton-lactate co-transporter MCT1)
and bicarbonate (through the sodium-bicarbonate co-transporter NBC or the chloride-
bicarbonate exchanger AE). Here we show that chronic treatment with fluoxetine increases
astroglial pHi by stimulating NHE1-mediated proton extrusion. At a clinically relevant
concentration of 1 µM, fluoxetine significantly increased astroglial pHi from 7.05 to 7.34
after 3 weeks and from 7.18 to 7.58 after 4 weeks of drug treatment. Stimulation of NHE1 is
a result of transporter phosphorylation mediated by several intracellular signaling cascades
that include MAPK/ERK1/2, PI3K/AKT and ribosomal S6 kinase (RSK). Fluoxetine stimulated
phosphorylation of ERK1/2, AKT and RSK in a concentration dependent manner. Positive
crosstalk exists between two signal pathways, MAPK/ERK1/2 and PI3K/AKT activated by
fluoxetine since ERK1/2 phosphrylation could be abolished by inhibitors of PI3K, LY294002
and AKT, triciribine, and AKT phosphorylation by inhibitor of MAPK, U0126. As a result,
RSK phosphorylation was not only inhibited by U0126 but also by inhibitor of LY294002.
The NHE1 phoshorylation resulted in stimulation of NHE1 activity as revealed by the
NH4Cl-prepulse technique; the increase of NHE1 activity was dependent on fluoxetine
concentration, and could be inhibited by both U0126 and LY294002. Our findings suggest
that regulation of astrocytic pHi and brain pH may be one of the mechanisms underlying
fluoxetine action.
Keywords: astrocytes, fluoxetine, pHi, NHE1, ERK1/2, AKT
INTRODUCTION
The most primary and fundamental astroglial function lies in
providing the homeostasis of the central nervous system (CNS).
Numerous molecular cascades expressed (often specifically) in
astrocytes control interstitial concentration of principal ions,
regulate movement and metabolism of major neurotransmitters,
supply neurones with energy substrates and contribute to
tissue defence through, for example, secreting scavengers of
reactive oxygen species (Deitmer and Rose, 2010; Rose et al.,
2013; Verkhratsky et al., 2015). Astroglial cells are involved
in regulation of interstitial pH by transporting both protons
(mostly through sodium-proton transporter 1, NHE1, glutamate
transporters EAAT1/2 and proton-lactate co-transporter MCT1)
and bicarbonate (through the sodium-bicarbonate co-transporter
NBC or the chloride-bicarbonate exchanger AE; see (Deitmer
and Chesler, 2009; Deitmer and Rose, 2010)). The NHE1
or a solute carrier family 9 member 1, SLC9A1 represents
the major pathway for H+ extrusion from astrocytes, in
exchange for Na+; the NHE1 is electro-neutral antiporter with
a stoichiometry 1Na+: 1H+ (Boedtkjer et al., 2012). Similarly
to many other astroglial ion transporters NHE1 is regulated by
a transmembrane Na+ gradient being thus under control of
astroglial Na+ signaling (Kirischuk et al., 2012; Rose and Karus,
2013).
Astroglial dysfunction, pathological remodeling or reactivity
contribute to pathogenesis of virtually all neurological diseases
(Verkhratsky et al., 2013, 2014a) including neuropsychiatric
disorders (Verkhratsky et al., 2014b). In particular evidence is
constantly accumulating indicative of significant contribution
of astroglia to major depression (MD). The number of
glial fibrillary acidic protein (GFAP)-positive astroglial cells is
conspicuously decreased in the brains of depressed patients
(Rajkowska and Miguel-Hidalgo, 2007; McNally et al., 2008;
Rajkowska and Stockmeier, 2013). Similarly, down-regulation
of another astroglial marker, protein S100β, has been observed
in the ventral prefrontal cortex of depressed suicide victims
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(Klempan et al., 2009). At the same time antidepressant
treatment reversed these MD-associated astroglial deficits as
an increase in expression of astroglial markers GFAP, S100β
and aldehyde dehydrogenase 1 family, member L1 (ALDH1L1)
were revealed in the post-mortem analysis (Barley et al.,
2009).
Deregulation of CNS pH homeostasis is a notable feature
of mood disorders. In patients with bipolar disorders the
intracellular pH (pHi) in neural cells is decreased in the euthymic
state as measured by 31P-MRS (Kato et al., 1994; Iwanaga et al.,
1996; Hamakawa et al., 2004). At the same time in MD patients
treated with antidepessants the pHi was not significantly different
from the control group (Kato et al., 1998). Since astrocytes
significantly contribute to regulation of both pHi and pH of the
interstitium we performed in depth analysis of the expression and
function of astroglial NHE1 by treatment with most common
antidepressant drug fluoxetine. We further studies intracellular
pathways involved in fluoxetine-dependent regulation of NHE1.
MATERIALS AND METHODS
ASTROGLIAL CULTURES
Primary cultures of astrocytes were prepared from the neopallia
of the cerebral hemispheres of newborn CD-1 mice (all areas
above and lateral to the lateral ventricles) by vortexing and
filtering through nylon meshes with pore sizes of 80 and
subsequently 10 µm as previously described (Hertz et al.,
1998; Hertz, 2012), with minor modifications (Li et al., 2009).
The cells were planted in 60-mm Falcon Primaria dishes or
on coverslips coated with polylysine. The culture medium
was a Dulbecco’s Medium Essential Medium (DMEM) with
7.5 mM glucose, initially containing 20% horse serum, and the
cultures were incubated at 37◦C in a humidified atmosphere
of CO2/air (5:95%). The medium was exchanged with fresh
medium of similar composition on day 3, and subsequently,
every 3–4 days. From day 3, the serum concentration was
reduced to 10%, and after 2 weeks, 0.25 mM dibutyryl cyclic
AMP (dBcAMP) was included in the medium, which leads
to a morphological and functional differentiation of astrocytes
(Meier et al., 1991; Hertz et al., 1998). Characteristics, usage
and advantages of these cultures has recently been authoritatively
reviewed (Lange et al., 2012). Ontogenetic similarity with freshly
isolated astrocytes in gene development has been reported by
ourselves (Li et al., 2012b); similarly there is evidence for
identical drug-induced changes in gene expression between in
vitro and in vivo assessed astrocytes (Li et al., 2012a; Song et al.,
2012).
WESTERN BLOTTING
The protein content was determined in the homogenates by
the Lowry method (Lowry et al., 1951), using bovine serum
albumin (BSA) as the standard. Samples containing 75 µg
protein were applied on slab gels of 10% polyacrylamide. After
transfer to nitrocellulose membranes, the samples were blocked
by 5% skimmed milk powder in TBS-T for 1 h, and the
polyvinylidene difluoride (PVDF) membranes were incubated
with the first antibody, specific to specific to p-ERK, ERK,
p-ribosomal S6 kinase (RSK) or β-actin for 2 h at room
temperature, or specific to p-AKT or AKT overnight at 4◦C. After
washing, the blots were incubated with peroxidase-conjugated
affinity-purified goat-anti-mouse or goat-anti-rabbit horseradish
antibody for 2 h. Staining was visualized by ECL detection
reagents. Digital images obtained using Gel-Imaging System
(Tanon 4200, Shanghai, China). Optical density for each band
was quantified using the Window AlphaEase TM FC 32-bit
software.
IMMUNOPRECIPITATION ANDWESTERN BLOTTING FOR NHE1
The phosphorylation level of NHE1 was determined by
immunoprecipitation with an antibody recognizing the phospho-
Ser 14-3-3 which binds to p-NHE1 as previously reported
(Snabaitis et al., 2006; Luo et al., 2007). After homogenization,
whole cell lysates (1,000 µg) were incubated with 4 µl of anti-
mouse phospho-Ser 14-3-3 protein binding motif antibody for
12 h at 4◦C. Thereafter 50 µl of washed Protein A/G PLUS—
agarose bead slurry was added, and the mixture was incubated
for another 2 h at 4◦C. The agarose beads were collected by
pulsing centrifuge (5 s in the microcentrifuge at 14,000 g),
the supernatant drained off and the beads boiled for 5 min.
Thereafter, the supernatant was collected by pulsing centrifuge
and the entire immunoprecipitates were subjected to 8% SDS-
polyacrylamide gel electrophoresis (PAGE). After transfer to
PVDF memebranes, the membranes were incubated with the
antibody specific to NHE1 at a 1:500 dilution overnight at 4◦C
and anti-mouse antibody at a 1:2000 dilution for 2 h at room
temperature.
MONITORING OF pHi
The fluorescent pH-sensitive indicator BCECF-AM and an
Olympus IX71 live cell imaging fluorescence microscope
(Tokyo, Japan) were used to detect pHi in individual cells
as described by Grant and Acosta (1997) and Manning and
Sontheimer (1999). After washing with 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer (NaCl: 140 mM;
KCl: 5.36 mM; MgSO4: 0.81 mM; CaCl2: 1.27 mM; KH2PO4:
0.44 mM; Na2HPO4: 0.33 mM; glucose: 5.55 mM; HEPES:
20 mM; pH: 7.4), cells were loaded with 5 µM BCECF-AM
for 30 min at 37◦C. After washing twice with HEPES buffer,
fluorescence was excited at 440 and 490 nm and emission
monitored at 530 nm. The fluorescence ratio (490/440 nm) was
determined and calibrated to yield pHi values by interpolation
between the measured fluorescence ratios in a similar culture
after 20 min of exposure to one of 3 calibration buffers (pH:
6.3, 6.9 or 7.5; KCl: 130 mM; MgCl2: 1 mM; HEPES: 15 mM;
MES: 15 mM). The calibration buffer also contained 56 µM
nigericin, an H+/K+ exchanger, in order to equilibrate pHi with
extracellular pH. Steady-state pHi was determined as the average
of five individual readings, each from six 20 s intervals (Song et al.,
2008, 2013).
Acid challenge was performed by the NH4Cl-prepulse
technique (Boron and De Weer, 1976; McAlear and Bevensee,
2004). Cells were washed twice after BCECF-AM loading.
Intracellular fluorescence ratio was determined at 25 s interval.
Cells were bathed in HEPES buffer during the first four cycles,
exposed to 20 mM NH4Cl added to the HEPES buffer with an
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equiosmolar reduction in the NaCl concentration during the next
five cycles, and again incubated in HEPES buffer during the last
twenty-seven 25 s intervals. Recovery of pHi (∆pHi) during the
last twenty-seven 25 s intervals was calculated by subtracting the
pHi after about 2 min (five cycles) exposure to NH4Cl from
the pHi measured every minute during the recovery for total of
10 min, and NHE activity was determined as ∆pHi/∆t (Song
et al., 2008, 2013).
CHEMICALS
Chemicals for culture media and dBcAMP were purchased from
Sigma (St. Louis, MO, USA) and horse serum from Invitrogen
(Carlsbad, CA, USA). Fluoxetine, SB204741 (N-(1-methyl-5-
indolyl)-N′-(3-methyl-5-isothiazolyl) urea), triciribine hydrate
and first antibodies, raised against β-actin were also purchased
from Sigma (St. Louis, MO, USA). The U0126 (1,4-diamino-2,3-
dicyano-1,4-bis[2-aminophenylthio]butadiene) and LY294002
(2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) were
obtained from Calbiochem (La Jolla, CA, USA). Santa Cruz
Biotechnology (Santa Cruz, CA, USA) supplied first antibodies,
raised against ERK (K-23), sc-94, against phosphorylated ERK (E-
4), sc-7383, against phosphorylated AKT1/2/3 (Ser 473), sc-33437
and against phosphorylated RSK1/2 (Thr 359/Ser 363), sc-12898-
R. Protein A/G PLUS-agarose, sc-2003 were also purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). The rabbit
polyclonal antibody against AKT and phosphor-(Ser) 14-3-3
binding motif antibody were purchased from Cell Signaling
Technology (Danvers, MA, USA). Chemicon (Temecula, CA,
USA) supplied the first antibody, raised against NHE1. The
second antibody goat anti-mouse IgG HRP conjugate (W4021)
was from Promega (Madison, WI, USA) and goat anti-rabbit
IgG HRP conjugate (sc-2004) from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). ECL detection reagents were from
Amersham Biosciences, Buckinghamshire, UK. Invitrogen Corp.
(Carlsbad, CA, USA) provided BCECF-AM, an acetoxymethyl
(AM) ester of 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein
(BCECF).
STATISTICS
Differences between multiple groups were evaluated by one-
way analysis of variance (ANOVA) followed by Fisher’s least
significant difference (LSD) multiple comparison test for unequal
replications. The level of significance was set at P < 0.05.
RESULTS
TREATMENT WITH FLUOXETINE INCREASES ASTROGLIAL pHi
Chronic treatment with fluoxetine caused a concentration-
and time-dependent intracellular alkalinization (Figure 1).
In astrocytes exposed to 10 µM fluoxetine for 3 days the
pHi inreased from 7.05 ± 0.13 (n = 32) to 7.48 ± 0.06
(n = 32) after 3 days of treatment (Figure 1A). When cells
were incubated with 1 µM fluoxetine (which concentration
is closer to therapeutically relevant) the pHi did not change
during the first week of treatment (Figure 1B), with a trend
towards an increase after 2 weeks of treatment, which was not
significant. After 3 and 4 weeks of treatment, pHi, however,
increased significantly. Chronic treatment with 1 µM fluoxetine
FIGURE 1 | Chronic treatment with fluoxetine increases pHi in primary
cultured astrocytes. (A) The pHi values measured in control cells or in
cells treated with 10 µM fluoxetine for 3 days. All results are means of 32
cells from 3 coverslips. SEM values are indicated by vertical bars.
*Indicates statistically significant (P < 0.05) difference from control group.
(B) The pHi values were measured from control cells and cells treated with
1 µM fluoxetine for 1, 2, 3 or 4 weeks. All results are means of 114 to 178
cells from 6 to 9 coverslips (1 week: control, n = 156 cells from 8 separate
coverslips; fluoxetine, n = 178 cells from 9 coverslips. 2 week: control,
n = 167 cells from 9 separate coverslips; fluoxetine, n = 119 cells from 6
coverslips. 3 week: control, n = 134 cells from 7 separate coverslips;
fluoxetine, n = 165 cells from 8 coverslips. 4 week: control, n = 114 cells
from 6 separate coverslips; fluoxetine, n = 153 cells from 8 coverslips.).
SEM values are indicated by vertical bars. *Indicates statistically significant
(P < 0.05) difference from control group at the same treatment period;
**Significant (P < 0.05) difference from all other groups.
for 3 weeks increased pHi from 7.05 ± 0.02 (n = 134)
to 7.34 ± 0.02 (n = 165), and for 4 weeks from 7.18 ±
0.02 (n = 114) to 7.58 ± 0.01 (n = 153). Alkalinization of
astroglial cytoplasm indicates, most likely, an increase in H+
extrusion which, arguably, may result from an increase in
activity of NHE1 that represents the main pathway for proton
efflux.
FLUOXETINE INDUCES PHOSPHORYLATION OF NHE1
The activity of NHE1 is known to be regulated by the transporter
phosphorylation (Moor and Fliegel, 1999). This phosphorylation
indeed takes place in cultured astrocytes exposed to fluoxetine,
as demonstrated on Figure 2. Phosphorylation of NHE1 in
cells treated with 10 µM fluoxetine occurs rapidly reaching its
maximum after 40 min and beginning to decline after 60 min
(Figure 2A). Exposure of cultured astrocytes to 1 µM fluoxetine
also induced NHE1 phosphorylation (Figure 2B).
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FIGURE 2 | Acute effect of fluoxetine on phosphorylation of NHE1.
(A) Cells were incubated with 10 µM fluoxetine for 0 (Control), 0.5, 1, 5, 10,
20, 40 or 60 min. Top: Immunoblots from representative experiments.
Bands of 105 kDa represent p-NHE1. Similar results were obtained from
three independent experiments. Bottom: Average NHE1 phosphorylation
was quantified as scanned band intensity of NHE1 and normalized vs. band
intensity from the control group. SEM values are indicated by vertical bars.
*Indicates statistically significant (P < 0.05) difference from control, 0.5, 1,
20 and 40 min groups. **Indicates statistically significant (P < 0.05)
difference from control, 0.5, 1, 5, 10, and 60 min groups. (B) Cells were
incubated with 0 (Control) or 1 µM fluoxeine for 20 min. Left: Immunoblots
from representative experiments. Bands of 105 kDa represent p-NHE1.
Similar results were obtained from five independent experiments. Right:
Average NHE1 phosphorylation was quantified as scanned band intensity of
NHE1 and normalized vs. band intensity from the control group. SEM
values are indicated by vertical bars. *Indicates statistically significant (P <
0.05) difference from control group.
INTERACTION BETWEEN PI3K/AKT AND MAPK/ERK
Pharmacological experiments described in previous section
highlighted the possible role for PI3K/AKT and MAPK/ERK
signaling pathways. Acute (20 min) treatment of astroglial cells
with fluoxetine indeed triggered ERK1/2 phosphorylation in
concentration-dependent manner (Figure 3). The fluoxetine-
dependent ERK1/2 phosphorylation was inhibited by 10 µM
U0126 (Figure 3A). Similarly ERK1/2 phopshorylation was
suppressed by 25 µM of LY294002, the PI3K inhibitor and by
10 µM triciribine, the AKT inhibitor (Figure 3B) indicating
signaling downstream of PI3K and AKT. Fluoxetine at 1 and
10 µM increased AKT phosphorylation (Figure 4). Fluoxetine-
dependent AKT phosphoryation was abolished by 25 µM
LY294002 (Figure 4A) and by 10 µM U0126 (Figure 4B).
RSK PHOSPHORYLATION
Fluoxetine also potentiated the phosphorylation of RSK in
cultured astrocytes. Treatment of cells with 1 and 10 µM
FIGURE 3 | ERK1/2 phosphorylation induced by fluoxetine requires
MEK and AKT phosphorylation. (A,B) Immunoblots from representative
experiments. (A) after pre-treatment in serum-free medium with or without
10 µM of MEK inhibitor U0126, 25 µM of PI3K inhibitor LY294002 or 10 µM
of AKT inhibitor triciribine (B) for 15 min, cells were incubated for 20 min
with 0 (Control), 0.1, 0.5, 1, 10 µM fluoxetine. Bands of 44 and 42 kDa
represent p-ERK1 (phosphorylated ERK1) and p-ERK2 (phosphorylated
ERK2), respectively (upper rows), or total ERK1 and ERK2 (lower rows).
Similar results were obtained from five independent experiments. (C)
Average ERK phosphorylation was quantified as ratios between p-ERK1 and
ERK1 (Top) and between p-ERK2 and ERK2 (Bottom). Ratios between
p-ERK1 and ERK1 or p-ERK2 and ERK2 were normalized to the control. SEM
values are indicated by vertical bars. *Indicates statistically significant (P <
0.05) difference from control group, 0.1 and 10 µM fluoxetine groups and
fluoxetine plus U0126, LY294002 or triciribine groups. **Indicates
statistically significant (P < 0.05) difference from all other groups.
fluoxetine for 20 min induced a significant increase of RSK
phosphorylation (Figure 5A). The level of RSK phosphorylation
was significantly higher at 10 µM than at 1 µM. The effect of
fluoxetine was abolished by 10 µM of U0126 and by 25 µM of
LY294002 (Figure 5B).
NHE1 ACTIVITY
Finally, we quantified NHE1 activity by measuring the rate of
pHi changes in individual cells following acidification induced
by 20 mM NH4Cl (Figure 6). In cells pretreated (for 20 min
before measurements) with 0.1, 1, or 10 µM of fluoxetine
the pHi recovered faster; and the rate of recovery increased
with an increase in fluoxetine concentration (Figure 6A).
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FIGURE 4 | AKT phosphorylation induced by fluoxetine requires MEK and
PI3K phosphorylation. (A) After pretreatment in serum-free medium with or
without 10 µM of MEK inhibitor U0126 for 15 min, cells were incubated for
20 min with 0 (Control), 0.1, 0.5, 1, 10 µM fluoxetine. Top: Immunoblots from
representative experiments. Bands of 60 kDa represent p-AKT (Ser473)
(upper rows), or total AKT (lower rows). Similar results were obtained in five
independent experiments. Bottom: Average AKT phosphorylation was
quantified as ratios between p-AKT and AKT and normalized to controls. SEM
values are indicated by vertical bars. *Indicates statistically significant (P <
0.05) difference from control group, 0.1 and 0.5 µM fluoxetine groups and
fluoxetine plus U0126 groups. (B) After pretreatment in serum-free medium
with or without 25 µM of PI3K inhibitor LY294002 for 15 min, cells were
incubated for 20 min with 0 (Control), 0.1, 0.5, 1, 10 µM fluoxetine. Top:
Immunoblots from representative experiments. Bands of 60 kDa represent
p-AKT (Ser473) (upper rows), or total AKT (lower rows). Similar results were
obtained in five independent experiments. Bottom: Average AKT
phosphorylation was quantified as ratios between p-AKT and AKT and
normalized to controls. SEM values are indicated by vertical bars. *Indicates
statistically significant (P < 0.05) difference from control group, 0.1 and
0.5 µM fluoxetine groups and fluoxetine plus LY294002 groups.
Fluoxetine-dependent increase in the activity of NHE1 was
abolished by 200 nM SB204741, an antagonist of 5-HT2B
receptor, by 10 µM of U0126 or by 25 µM of LY294002
(Figure 6B).
DISCUSSION
Proton homeostasis and maintenance of intra- and extracellular
pH in the brain is critically important for normal activity
of neural cells and therefore for brain functions. Decrease in
brain pH is associated with variety of pathological conditions,
such as ischemia and epilepsy (Katsura and Siesjo, 1998).
The pH of the extracellular fluid is affected by numerous
pH regulating systems localized in neurones and neuroglia
(for review, see McAlear and Bevensee, 2004; Deitmer and
Chesler, 2009). Astroglia play an important role in regulation
of interstitial pH and pHi by their acid-loading, acid-extruding
and bicarbonate transporting systems (McAlear and Bevensee,
2004; Deitmer and Chesler, 2009). Previously, we have reported
that chronic treatment of astrocytes with three antibipolar
drugs induced intracellular alkalization (Song et al., 2008,
2013). Specifically, lithium acutely stimulated proton efflux
through NHE1 by direct action at the extracellular site (Song
et al., 2008); whereas carbamazepine and valproic acid up-
regulated expression of electrogenic Na+/HCO3− co-transporter
NBCe1/SLC4A4 (Song et al., 2013). In the present paper we
performed systematic investigation of the effects of fluoxetine on
pH regulation and intracellular signalling cascades in astrocytes.
In particular, we investigated effects of fluoxetine on (i) the
pHi; (ii) the NHE1 phosphorylation; (iii) the interaction of
MAPK/ERK1/2 and PI3K/AKT signal pathways; (iv) the RSK
phosphorylation; and (v) the NHE1 activation following acidic
stress.
As expected, both NHE1 and RSK were phosphorylated by
acute treatment with fluoxetine, suggesting RSK was involved
in NHE1 phosphorylation. This was suppressed by inhibition
of either MAPK/ERK1/2 or PI3K/AKT signaling pathways,
indicating the interaction between them is required, although
RSK is positioned downstream of MAPK/ERK1/2 (Figure 7).
The NHE1 activity measured by NH4Cl challenge was blocked
by inhibition of either MAPK/ERK1/2 or PI3K/AKT pathway,
and by an antagonist of 5-HT2B receptor, demonstrated that
the stimulation of NHE1 by fluoxetine is mediated by 5-HT2B
receptor. Previously, we reported that fluoxetine acts as agonists of
5-HT2B receptors in astrocytes (Kong et al., 2002). All three 5-HT2
receptors, 5-HT2A, and 5-HT2B and 5-HT2C receptors are Gq/11
protein-coupled, and stimulation of these receptors activates
phospholipase C (PLC), thus generating diacyglycerol (DAG) and
inositol 1,4,5-trisphosphate (InsP3). The fluoxetine-induced and
5-HT2B receptor-mediated ERK1/2 phosphorylation as well as the
effect of fluoxetine on epidermal growth factor receptor (EGFR)
phosphorylation could be abolished by (i) AG1478, an inhibitor
of the EGFR tyrosine kinase and by (ii) GM6001, a potent
and broad-based inhibitor of Zn2+-activated metalloproteinases
(Li et al., 2008), suggesting the role of EGFR transactivation.
Frontiers in Cellular Neuroscience www.frontiersin.org March 2015 | Volume 9 | Article 61 | 5
Ren et al. Stimulation of NHE1 by fluoxetine in astrocytes
FIGURE 5 | RSK phosphorylation induced by fluoxetine requires MEK
and PI3K phosphorylation. After pretreatment in serum-free medium with
or without 10 µM of MEK inhibitor U0126 or 25 µM of PI3K inhibitor
LY294002 for 15 min, cells were incubated for 20 min with 0 (Control), 1,
10 µM fluoxetine. (A) Immunoblots from representative experiments.
Bands of 90 and 46 kDa represent p-RSK (phosphorylated RSK) (upper row)
and β-actin (lower row), respectively. Similar results were obtained in four
independent experiments. (B) Average RSK phosphorylation was
quantitated as ratios between p-RSK and β-actin and normalized to controls.
SEM values are indicated by vertical bars. *Indicates statistically significant
(P < 0.05) difference from all other groups.
Fluoxetine also stimulates PI3K/AKT signal pathway by EGFR
transactivation in astrocytes (Peng and Huang, 2012). The 90 kDa
RSK is the downstream effector of ERK1/2. The RSK belongs
to highly conserved Ser/Thr kinases that are involved in many
cellular processes (Anjum and Blenis, 2008), and is also known
as a NHE1 kinase (Vik and Ryder, 1997).
We found that fluoxetine at clinically relevant concentrations
induced phosphorylation of both ERK1/2 and AKT in astrocytes.
Conceptually, the PI3K/AKT and Raf/MAPK/ERK1/2 represent
two parallel signal pathways, although, the interactions between
PI3K/AKT and Raf/MAPK/ERK1/2 cascades may occur at several
different stages and could be either positive or negative. In
the present work we found that PI3K/AKT and MAPK/ERK1/2
signaling potentiated each other (Figure 7). Previously, we
reported that either PI3K or AKT may stimulate the activity
of Raf, MAPK or ERK1/2 in ammonium-induced ERK1/2
phosphorylation in astrocytes, since ERK1/2 phosphorylation was
inhibited by both the MAK inhibitor U0126 and PI3K/AKT
inhibitor, LY294002 (Dai et al., 2013). A similar pattern has been
observed for effects (i) of insulin or insulin-like growth factor-1
(IGF-1) on skeleton muscle cells (Cross et al., 1994) or insulin
receptor-transfected Chinese hamster ovary cells (Welsh et al.,
1994); (ii) of platelet-activating factor on guinea pig neutrophils
(Ferby et al., 1994); (iii) of interleukin-2 on T-lymphocytes
(Karnitz et al., 1995); and (iv) of platelet-derived growth factor
FIGURE 6 | Acute effect of fluoxetine on recovery of pHi from an acid
load in primary cultured of astrocytes, which were exposed to 20 mM
NH4Cl for 2 min. (A) A representative experiment showing recovery of pHi
after 20 min of incubation with 0 (control; diamonds), 0.1 (squares), 0.5
(triangles), 1 (asterisks) or 10 µM (circles) fluoxetine. (B) Recovery of pHi is
presented as ∆pHi /∆t. All results are means of ∆pHi /∆t of 60 to 120 cells
from 4 to 6 coverslips (control, n = 99 cells from 5 separate coverslips;
0.1 µM fluoxetine, n = 77 cells from 4 coverslips; 0.5 µM fluoxetine, n = 60
cells from 4 separate coverslips; 1 µM fluoxetine, n = 72 cells from 6
separate coverslips; 10 µM fluoxetine, n = 120 cells from 6 separate
coverslips). SEM values are indicated by vertical bars. *Indicates statistically
significant (P < 0.05) difference from control, 0.1 and 10 µM groups;
**Significant (P < 0.05) difference from all other groups. (C) After
pretreatment with or without 200 nM of 5-HT2B receptor antagonist
SB204741, 10 µM of MEK inhibitor U0126 or 25 µM of PI3K inhibitor
LY294002 for 15 min, cells were incubated for 20 min with 0 (Control), 1,
10 µM fluoxetine. Recovery of pHi is presnetd as ∆pHi /∆t. All results are
means of ∆pHi /∆t of 36 to 90 cells from 3 to 5 coverslips (control, n = 90
cells from 5 separate coverslips; 1 µM fluoxetine, n = 90 cells from 5
separate coverslips; 10 µM fluoxetine, n = 90 cells from 5 separate
coverslips; SB204741, n = 58 cells from 3 separate coverslips; SB204741
plus 1 µM fluoxetine, n = 75 cells from 4 separate coverslips; SB204741
(Continued )
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FIGURE 6 | Continued
plus 10 µM fluoxetine, n = 65 cells from 3 separate coverslips; U0126,
n = 43 cells from 3 separate coverslips; U0126 plus 1 µM fluoxetine, n = 48
cells from 3 separate coverslips; U0126 plus 10 µM fluoxetine, n = 36 cells
from 3 separate coverslips; LY294002, n = 82 cells from 5 separate
coverslips; LY294002 plus 1 µM fluoxetine, n = 82 cells from 5 separate
coverslips; LY294002 plus 10 µM fluoxetine, n = 88 cells from 5 separate
coverslips). SEM values are indicated by vertical bars. *Indicates statistically
significant (P < 0.05) difference from all other groups.
FIGURE 7 | Possible signaling cascades mediating fluoxetine-induced
stimulation of ptoron transport in astrocytes. Fluoxetine acts as an
agonist at 5-HT2B receptor. Stimulation of 5-HT2B receptor activates
phospholipase C (PLC), generating diacylglycerol (DAG) and inositol
1,4,5-trisphosphate (IP3) and leading to an increase of free cytosolic
calcium concentration and stimulation of matrix metalloproteinases
(MMPs), which in turn induced transactivation of EGF receptors. The
activation of EGF receptor stimulates MAPK/ERK and PI3K/AKT signaling
cascades with a positive feedback loop existing between these two
pathways. Ninety-kDa ribosomal S6 kinase (RSK or p90RSK ), downstream of
ERK can increase the activity of NHE1 by phosphorylation of Ser-703.
on fibroblasts and T-lymphocytes (Grammer and Blenis, 1997).
Although PI3K is one of the major downstream signals of
RAS small GTPases (Castellano and Downward, 2011), there is
also evidence that PI3K activates MAPK/ERK1/2 pathway at/or
upstream of RAS (Hawes et al., 1996). To the best of our
knowledge, our finding is the first report that MAPK/ERK1/2
potentiates the PI3K/AKT signaling pathway.
The pHi increases in astrocytes chronically treated with
fluoxetine in a time- and concentration-dependent manner.
This reflects changes in pH homeostasis that may influence
brain pH and astrocytic functions and may contribute to
the drug action. Changes in pHi significantly affects astroglial
physiology. Addition of lactate acid or a decrease of pHi
inhibits communications through gap junction and facilitates
internalization of Cx43 in astrocytes (Anders, 1988; Duffy et al.,
2004). Astrocytic proliferation is also regulated by changes in pHi
(Pappas et al., 1994). A decrease in pHi, for instance, inhibited
conversion of inactive phosphorylase b to active phosphorylase
a, thus decreasing glycogenolysis (Danforth, 1965). In the brain,
glycogen is located almost exclusively in astrocytes (Ibrahim,
1975); glycogen is rapidly consumed along with enhanced
neuronal activity (for example during whisker stimulation)
(Swanson et al., 1992), this process contributing to neuronal
energetics. The glycogenolysis is similarly important for many
signaling processes in astrocytes (Hertz et al., 2015). It is ideal
for such a role because it does not require phosphorylation
(Hertz et al., 2007); and it is regulated by physiological signals
including [Ca2+]i rises (Ozawa, 1972) by various transmitters
and by increases in extracellular K+ concentration (Hof
et al., 1988; Magistretti, 1988; Obel et al., 2012). Astroglial
release of ATP release stimulated by high K+, glutamate and
adenosine is also dependent on glycogenolysis (Xu et al., 2014).
In summary, fluoxetine-induced intracellular alkalization may
benefit astrocytic gap junction and signal transduction. It will
be interesting to know whether these astrocytic functions are
deregulated in depressed animals.
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